Sign in
Taking peopleNo phase

Following adults with advanced chronic liver disease to learn what leads to liver problems

Follows adults with advanced chronic liver disease for 10 years, with yearly liver scans.

Key facts

Who runs it
Chinese University of Hong Kong
Where
Hong Kong1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Natural History of Advanced Chronic Liver Diseases
Status
Recruiting
People taking part
500 people, planned
Started
25 Sept 2024
Expected to end
Dec 2035
Type of study
Observational
Treatments tested
  • Transient elastography
Record updated
20 October 2026

Who can take part

The trial is looking for adults with advanced chronic liver disease (ACLD), including cirrhosis (scarring of the liver). Participants are followed for 10 years and have a yearly liver stiffness scan.

Age
18 years or older
Sex
All sexes
Disease stage
Advanced chronic liver disease. This means a liver stiffness result (LSM) above 10kPa, or signs of cirrhosis. Cirrhosis signs are a scarred liver and high pressure in the liver veins on ultrasound, or swollen veins in the food pipe or stomach seen on a camera test (OGD).
Earlier treatment
People who have had a liver transplant cannot join.
Biomarker or test result
Liver stiffness measurement (LSM) above 10kPa, or cirrhosis signs on ultrasound or OGD.
Main reasons for not taking part
  • Liver cancer (hepatocellular carcinoma, HCC) now or in the past
  • Past liver transplant
  • No spleen, or spleen removed by surgery
  • Serious illness with expected life span under 6 months
  • Pregnancy
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Aged 18 or above
  • Known ACLD, defined by:; LSM > 10kPa or; Clinical cirrhosis, suggested by 1. ultrasonography of the hepatobiliary system shows features of cirrhosis (e.g. shrunken and nodular liver) and portal hypertension (e.g. dilated portal vein, portal-systemic collaterals or varices, splenomegaly, ascites). 2. Oesophagogastroduodenoscopy (OGD) shows presence of oesophageal varices (OV) and/or gastric varices (GV) and/or portal hypertensive gastropathy

Who cannot take part

  • Current or past history of hepatocellular carcinoma (HCC)
  • History of liver transplantation
  • Asplenism or history of splenectomy
  • Serious medical illness with limited life expectancy of less than 6 months
  • Pregnancy
  • Unable to obtain or refusal of informed consent from patient

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Cirrhosis or advanced chronic liver disease

This trial is currently available in Hong Kong.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a retrospective-prospective registry cohort study. Patients with advanced chronic liver disease (ACLD) will be prospectively invited to this study. The study follow-up duration will be 10 years. The primary outcome is incident hepatic events and liver-related mortality. Participants will undergo annual transient elastography examination.

The group in the trial

  • Patients with advanced chronic liver disease

    Adult patients with advanced chronic liver disease

    Treatment: Transient elastography

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Natural History of Advanced Chronic Liver Diseases and Factors Associated With Hepatic Events - a Registry Study
Plain-language title
Following adults with advanced chronic liver disease to learn what leads to liver problemsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT07042308, who can take part
Record updated
20 October 2026